Byron Zhao

Title: Byron Zhao - Innovator in Potassium Channel Research

Introduction

Byron Zhao is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of biochemistry, particularly in the study of potassium channels. His innovative work has led to the development of a patent that holds promise for medical applications.

Latest Patents

Byron Zhao holds a patent for "Potassium channel subunit polypeptide and polynucleotide compositions and uses therefor." This invention provides novel potassium channel subunits, denoted as Kv-SL1 and Kv-SL2, collectively referred to as Kv-SL. The patent also includes polynucleotides that identify and encode these subunits. Additionally, it offers expression vectors and host cells that comprise the nucleic acid sequence encoding Kv-SL. The invention further encompasses antibodies of Kv-SL and methods for diagnosing and treating diseases associated with the expression of Kv-SL, along with screening assays utilizing the protein, nucleotide, and antibody compositions. Byron Zhao has 1 patent to his name.

Career Highlights

Byron Zhao is currently employed at Elan Pharmaceuticals, Inc., where he continues to advance his research in the field of potassium channels. His work is pivotal in understanding the role of these channels in various diseases, which could lead to new therapeutic strategies.

Collaborations

Throughout his career, Byron has collaborated with esteemed colleagues, including Raymond A Chavez and John R Forsayeth. These partnerships have enhanced the scope and impact of his research.

Conclusion

Byron Zhao is a distinguished inventor whose work on potassium channel subunits has the potential to influence medical science significantly. His contributions to the field are noteworthy, and his ongoing research at Elan Pharmaceuticals, Inc. continues to pave the way for future innovations.